- Report
- April 2025
- 93 Pages
Global
From €5308EUR$5,600USD£4,434GBP
- Report
- April 2023
- 120 Pages
Global
From €4502EUR$4,750USD£3,761GBP
- Report
- September 2018
- 112 Pages
Global
From €2606EUR$2,750USD£2,178GBP
- Report
- June 2023
- 114 Pages
Global
From €3500EUR$3,956USD£3,026GBP
- Report
- March 2024
- 132 Pages
Global
From €900EUR$950USD£752GBP
- Book
- November 2008
- 496 Pages
The In Vivo Toxicology market is a segment of the Drug Discovery industry that focuses on the safety and efficacy of drugs and other compounds. It involves the use of animal models to assess the potential toxicity of a compound before it is tested in humans. This process helps to identify potential adverse effects and to ensure that the drug is safe for human use. In Vivo Toxicology also helps to identify the optimal dose of a drug and to determine the pharmacokinetics of a compound.
In Vivo Toxicology services are provided by a variety of companies, including Charles River Laboratories, Covance, Eurofins Scientific, and WuXi AppTec. These companies offer a range of services, such as preclinical safety assessment, pharmacokinetic studies, and drug metabolism studies. They also provide services related to the development of animal models, such as the generation of genetically modified animals. Show Less Read more